Michigan Medicine’s chief population health officer, Hae Mi Choe, PharmD, recently won a leadership award from the American Society of Health-System Pharmacists. Dr. Choe received the ASHP board’s Distinguished Leadership Award for her work in catalyzing “pharmacists’ involvement in accountable…
Pharmacy
President Donald Trump is threatening to impose tariffs of up to 200% on pharmaceuticals imported into the U.S., The Hill reported July 8. “If they have to bring the pharmaceuticals into the country, the drugs and other things into the…
A federal judge has ordered CVS Health subsidiary Omnicare to pay $948.8 million in damages and penalties for submitting fraudulent Medicare and Medicaid claims. The order, issued July 7 in the U.S. District Court for the Southern District of New…
President Donald Trump sent letters to leaders of 14 countries, informing them of new additional tariff rates, some as high as 40%, CNN reported July 8. The tariffs were scheduled to take effect July 9, but have been delayed until…
The FDA has approved Ekterly, the first oral treatment for hereditary angioedema. With the approval, the drug is now cleared for treatment in adults and children ages 12 and older. Before Ekterly, all approved on-demand treatments for hereditary angioedema required…
Advertisement
A commonly prescribed medication used to counteract lung cancer therapy side effects could be minimizing a cancer treatment’s efficacy, according to research from Los Angeles-based Keck Medicine of USC. To evaluate how baseline steroid use can affect immune checkpoint inhibitor…
The FDA has approved Novartis Coartem Baby, the first malaria treatment designed for newborns and young infants. The medicine, developed in collaboration with Medicines for Malaria Venture, a nonprofit partnership, is intended for babies weighing less than 10 pounds, an…
Cuts at the FDA are slowing inspections of overseas drug manufacturers, prompting concerns from former and current employees that medication safety could be at risk, ProPublica reported July 7. Dozens of individuals who help coordinate the travel for complex inspections…
A late-stage trial testing Novartis’ Cosentyx in individuals with giant cell arteritis failed to meet its primary endpoint. The phase 3 study tested Cosentyx alongside a 26-week steroid taper and compared it with a placebo along with a longer, 52-week…
The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the Congressional Budget Office. CMS gained the authority to negotiate…